With the ready availability of spatial databases and Geographical Information System (GIS) software, statisticians are increasingly encountering multivariate modeling settings featuring associations of more than one type: spatial associations between data locations, and associations between the variables within the locations. While flexible modeling of multivariate point-referenced data have recently been addressed using a linear model of coregionalization (LMC; see e.g. Gelfand et al., 2004) , existing methods for multivariate areal data (e.g. Kim et al., 2001; Gelfand and Vounatsou, 2003; Jin et al., 2005) typically suffer from unnecessary restrictions on the covariance structure or undesirable dependence on the conditioning order of the variables. In this paper we propose a class of Bayesian hierarchical models for multivariate areal data that avoids these restrictions, permitting flexible and order-free modeling of correlations both between variables and across areal units. Our framework encompasses a rich class of multivariate conditionally autoregressive (MCAR) models that are computationally feasible via modern Markov chain Monte Carlo (MCMC) methods. We illustrate the strengths of our approach over existing models using simulation studies, and also offer a real-data application involving annual lung, larynx, and esophagus cancer death rates in Minnesota counties between 1990 and 2000.
Introduction
The last decade has seen an explosion of interest in disease mapping, with recent developments in advanced spatial statistics and increasing availability of computerized Geographic Information System (GIS) technology. For example, the databases from the National Center for Health Statistics (NCHS) or from the Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute, publicly available to anyone with a web browser, provide an enormous supply of georeferenced data.
Disease mapping is an epidemiological technique used to describe the geographic variation of disease and to generate etiological hypotheses about the possible causes for apparent differences in risk. Disease maps are used to highlight geographic areas with high and low incidence or mortality rates of a specific disease, and the variability of such rates over a spatial domain. They can also be used to detect spatial clusters which may be due to common environmental, demographical, or cultural effects shared by neighboring regions. However, mapping of crude incidence or mortality rates can be misleading when the population sizes for some of the units are small, resulting in large variability in the estimated rates, and making it difficult to distinguish chance variability from genuine differences. The correct geographic allocation of health care resources would be greatly enhanced by the development of statistical models that allow a more accurate depiction of "true" disease rates and their relation to explanatory variables (e.g. covariates).
For reasons of confidentiality or practicality, disease incidence or mortality data are often reported as counts or rates at a regional level (county, census tract, zip code, etc). Conditionally autoregressive (CAR) models have been widely used for disease mapping with such data. They allow us to borrow strength across regions by using not only the data from a given region, but also the data from neighboring regions. When we have multivariate areal (lattice) data (say, counts of p ≥ 2 diseases over the same regions), an obvious first choice would be to use p separate univariate CAR models.
But correlation across diseases may occur if they share the same set of (spatially distributed) risk factors, or are linked by etiology, a common risk factor, or an affected organ. Moreover, the presence of one disease might encourage or inhibit the presence of another over a region. A multivariate areal model can permit modeling of dependence among those diseases while maintaining spatial dependence between regions. Identifying similar patterns in geographical variation of related diseases in a multivariate way may provide more convincing evidence for any real clustering in the underlying risk than would be available from the analysis of any single disease separately.
Several multivariate areal models have been proposed to date, any of which could be applied to multiple disease mapping. The primary underlying challenge of multivariate areal modeling is to formulate valid probability models that account for association between different variables (e.g., diseases) within areal units along with the spatial association between areal units. While they provide valuable theoretical insight into joint modeling of areal data, current methods often fall short of offering a template that is at once versatile and practical. Mardia (1988) described the theoretical background for multivariate Gaussian Markov Random Field (MRF) specifications, extending the pioneering work of Besag (1974) , but used separable models that force identical spatial smoothing for all variables. The "twofold CAR" model of Kim et al. (2001) offers richer spatial covariance structures for counts of two different diseases over each areal unit, but its extension to the case of more than two variables is unclear. Knorr-Held and Best (2001) developed a latent variable "shared component" model for bivariate disease mapping; here extension to more than two diseases is possible (Held et al., 2005) , but can be awkward. Sain and Cressie (2002) discussed a multiobjective version of the conditional autoregressive model that allows for flexible modeling of the spatial dependence structure, the cross-correlations in particular, but may become computationally prohibitive. Carlin and Banerjee (2003) and Gelfand and Vounatsou (2003) developed essentially equivalent multivariate conditionally autoregressive (MCAR) models for hierarchical modeling to include non-separable models, but left room for further generality in the covariance structures. Adapting the multivariate point-level data approach of Royle and Berliner (1999) , Jin et al. (2005) proposed a generalized multivariate conditional autoregressive (GMCAR) model for areal data that formulates the joint distribution for a multivariate MRF by specifying simpler conditional and marginal models. These models are computationally efficient and allow sufficient flexibility in the specifications of the spatial covariance structure. Indeed, many of the above models arise as special cases of the GMCAR. However, an inherent problem with these methods is that their conditional specification imposes a potentially arbitrary order on the variables being modeled, as they lead to different marginal distributions depending upon the conditioning sequence. This problem is somewhat ameliorated in certain (e.g., medical and environmental) contexts where a natural order is reasonable, but in many disease mapping contexts this is not the case. Although Jin et al. (2005) suggest using model comparison techniques to decide upon the proper modeling order, since all possible permutations of the variables would need to be considered this seems feasible only with relatively few variables. In any case, the principle of choosing among conditioning sequences using model comparison metrics is perhaps not uncontroversial.
In this paper we develop an order-free framework for multivariate areal modeling that allows versatile spatial structures, yet is computationally feasible for many variables. Our approach is based on a linear model of coregionalization (LMC) that has recently been proposed for multivariate pointreferenced data (Wackernagel, 2003; Schmidt and Gelfand, 2003; Gelfand et al., 2004) . Essentially, the idea is to develop richer spatial association models using linear transformations of much simpler spatial distributions. In this paper, we apply the LMC approach to the analysis of multivariate areal data, with an eye toward developing models for multiple disease mapping. In the process, we arrive at a very versatile framework, which encompasses a rich class of MCAR models (including most of the existing models) as special cases. In particular, we consider modeling the annual mortality rates from lung, larynx, and esophageal cancer between 1990 and 2000 in Minnesota counties, a setting in which association would be expected both within and across the areal units.
The format of our paper is as follows. In Section 2, we briefly review the spatial modeling of a single disease and multiple diseases. In Section 3, we introduce new LMC-based ways of multivariate spatial modeling. Section 5 discusses the MCMC implementation of our proposed model, and evaluates our approach in terms of average mean square error (AMSE) and the Deviance Information Criteria (DIC) via simulation. Section 6 then illustrates our approach in the aforementioned multiple cancer data mapping setting. Finally, Section 7 summarizes our findings and suggests avenues for future research in this area.
Spatial modeling for disease mapping
Disease incidence or mortality data are often reported as counts or rates at a regional level (county, census tract, zip code, etc), and are called areal (or lattice) data. Markov random field (MRF) models for lattice data are based on the Markov property, where the conditional distribution of a site's response given the responses of all the other sites depends only on the observations in the neighborhood of this site. In this paper we define the neighborhood by area adjacency, although other definitions sometimes used (e.g., regions with centroids within a given fixed distance).
Spatial modeling of a single disease
Let Y i be the observed number of cases of a certain disease in region i, i = 1, . . . , n, and E i be the expected number of cases in this same region. Here the Y i are thought of as random variables, while the E i are thought of as fixed and known (and are often simply taken as proportional to the number of persons at risk in the region). For rare diseases, a Poisson model approximation to a binomial sampling distribution for disease counts is often used. Thus, a commonly used likelihood when mapping a single disease is
where µ i = x i β + φ i . The x i are explanatory, region-level spatial covariates, having parameter coefficients β. The parameter µ i represents the log-relative risk, estimates of which are often based on the departures of observed from expected counts. We place a form of Gaussian MRF model, commonly referred to as the conditionally autoregressive (CAR) prior, on the random effects φ =
where N n denotes the n−dimensional normal distribution, D is a n×n diagonal matrix with diagonal elements m i that denote the number of neighbors of area i, and W is the adjacency matrix of the map (i.e., W ii = 0, and W ii = 1 if i is adjacent to i and 0 otherwise). In the joint distribution (2), τ −1 is the spatial dispersion parameter, and α is the spatial autocorrelation parameter. The CAR prior corresponds to the following conditional distribution of φ i :
where i ∼ j denotes that region j is a neighbor (typically defined in terms of spatial adjacency) of region i. The CAR structure (2) reduces to the well-known intrinsic conditionally autoregressive (ICAR) model (Besag et al., 1991) if α = 1, or an independence model if α = 0. The ICAR model induces "local" smoothing by borrowing strength from the neighbors, while the independence model assumes independence of spatial rates and induces "global" smoothing. The smoothing parameter α in the CAR prior (2) controls the strength of spatial dependence among regions, though it has long been appreciated that a fairly large α may be required to deliver significant spatial correlation; see Wall (2004) for recent discussion and exemplification.
A similar approach proposes a Gaussian convolution prior for the modeling of the random effects φ. The random effects φ are assumed to be the sum of the two independent components with one having a Gaussian independence prior and the other a Gaussian ICAR prior (Besag et al., 1991) . With such a convolution prior, we may capture both the relative contributions of region-wide heterogeneity and local clustering. Although this method has limitations (see e.g. Banerjee, Carlin, and Gelfand, 2004, pp.163-165) , since the convolution process priors are among the most widely used we implement this model for our Minnesota cancer data analysis in Section 6.
Spatial modeling of multiple diseases
Now let Y ij be the observed number of cases of disease j in region i, i = 1, . . . , n, j = 1, . . . , p, and let E ij be the expected number of cases for the same disease in this same region. As in Section 2.1, the Y ij are thought of as random variables, while the E ij are thought of as fixed and known. For the first level of the hierarchical model, conditional on the random effects φ ij , we assume the Y ij are independent of each other such that
where the x ij are explanatory, region-level spatial covariates for disease j having (possibly regionspecific) parameter coefficients β j . Carlin and Banerjee (2003) and Gelfand and Vounatsou (2003) generalized the univariate CAR (2) to a joint model for the random effects φ ij under a separability assumption, which permits modeling of correlation among the p diseases while maintaining spatial dependence across space. Separability assumes that the association structure separates into a non-spatial and spatial component. More precisely, the joint distribution of φ is assumed to be
where
as the non-spatial precision matrix (inverse of dispersion matrix) between cancers, and ⊗ denotes the Kronecker product. We denote the distribution in (5) by M CAR(α, Λ). This distribution can be further generalized by allowing different smoothing parameters for each disease, i.e.,
Note that the off-diagonal block matrices (the R i 's) in the precision matrix in (6) are completely determined by the diagonal blocks. Thus, the spatial precision matrices for each disease induce the cross-covariance structure in (6).
Recently, Jin et al. (2005) developed a more flexible generalized multivariate CAR (GMCAR) model for the random effects φ. For example, in the bivariate case (p = 2), they specify the condi-
, and the marginal distribution of
, both of which are univariate CAR as in (2) . This formulation yields the models of Kim et al. (2001) as a special case and recognizes explicit smoothing parameters (η 0 and η 1 ) for the cross-covariances, unlike the MCAR models in (6) where the cross-covariances are not smoothed explicitly. Kim et al (2001) and Jin et al (2006) demonstrate that explicit smoothing of the cross-covariances yield better model fits to areally referenced bivariate data. However, to model the random effects φ with the GMCAR model, we need to specify the conditioning order, since different conditioning orders will result in different marginal distributions for φ 1 and φ 2 and, hence, different joint distributions for φ. As mentioned in Section 1, in disease mapping contexts a natural conditioning order is often not evident -a problem that is exacerbated when we have more than two diseases. What we seek, therefore, are models that avoid this dependence on conditional ordering, yet are computationally feasible with sufficiently rich spatial structures.
Order-free MCAR distributions
Our primary methodological objective is to formulate MCAR distributions that allow explicit smoothing of cross-covariances while at the same time not being hampered by conditional ordering.
The most natural model here would parametrize the cross-covariances themselves as D−γ ij W , instead of using the R j 's as in (6). Unfortunately, except in the separable model with only one smoothing parameter α, constructing such dispersion structures is not trivial and leads to identifiability issues on the γ's (see, e.g., Gelfand and Vonatsou, 2003) . Kim et al. (2001) resolve these identifiability issues in the bivariate setting using diagonal dominance, but recognize the difficulty in extending this to the multivariate setting. Our contribution here is to address this problem using a linear model of coregionalization (LMC). The LMC is a well-established tool used in multivariate geostatistics (Chilés and Delfiner, 1998; Wackernagel, 2003; Banerjee et al., 2004) to incorporate different spatial ranges for each variable. However, to date this technique has not been employed in areal modeling, which has instead traditionally relied upon conditional specifications.
It is worth pointing out that our use of the LMC here is somewhat broader than usually encountered in geostatistics. In geostatistics we typically transform independent latent effects, which suffices in meeting the primary goal of introducing a different spatial range for each variable. This is akin to introducing different smoothing parameters for each variable and indeed, as we show below in Section 3.2, independent latent effects lead to the M CAR(α 1 , . . . , α p ; Λ) in (6). However, to explicitly smooth the cross-covariances with identifiable parameters, we will relax the independence of latent effects. Still, in our ensuing parametrization, we are able to derive conditions that yield valid joint distributions. To be precise, let φ = (φ 1 , . . . , φ p ) be an np × 1 vector, where each
is n × 1 representing the spatial effects corresponding to disease j. We can write
is np × 1 with each u j being an n × 1 areal process. Indeed, a proper distribution for u ensures a proper distribution for φ subject only to the non-singularity of
A. The flexibility of this approach is apparent: we obtain different multivariate lattice models with rich spatial covariance structures by making different assumptions about the p spatial processes u j .
Case 1: Independent and identical latent processes
First, we will assume that the random spatial processes u j , j = 1, . . . , p, are independent and identical. Since each spatial process u j is a univariate process over areal units, we might adopt a CAR structure (2) for each of them, that is
Since the u j are independent of each other, the joint distribution of
defining Σ = AA . We denote the distribution in (8) (7), which is an ICAR, the joint distribution of φ in (8) becomes the multivariate intrinsic CAR (Gelfand and Vounatsou, 2003) .
Currently, the WinBUGS package (http://www.mrc-bsu.cam.ac.uk/bugs/welcome.shtml) can fit the M CAR(α = 1, Σ) distribution (using its mv.car distribution), but not the M CAR(α, Σ).
However through the LMC approach we still can fit the M CAR(α, Σ) in WinBUGS by writing φ = (A⊗ I n×n )u and assigning proper CAR priors (via the car.proper distribution) for each u j , j = 1, . . . , p with a common smoothing parameter α. Regarding the prior on A, note that since AA = Σ and A is the Cholesky decomposition of Σ, there is a one-to-one relationship between the elements of Σ and A. In Section 4, we argue that assigning a prior to Σ is computationally preferable.
Case 2: Independent but not identical latent processes
In Case 1, we assumed that the random spatial processes u j , j = 1, . . . , p were independent and identical. However, it will often be preferable to have p different spatial processes. In this subsection, we will continue to assume that the u j are independent, but relax their being identically distributed.
Adopting the CAR structure (2), the distribution of u j is assumed to be
where α j is the smoothing parameter for the jth spatial process. Since the u j 's are independent of each other and φ = (A ⊗ I n×n )u, the joint distribution of φ is
where Σ = AA and Γ is an np × np block diagonal matrix with n × n diagonal entries
In this case, from the joint distribution in (10) it can be seen that different joint distributions of φ having different covariance matrices emerge under different linear transformation matrices A. To ensure A is identifiable, we could again specify it to be the upper-triangular Cholesky decomposition of Σ, although this might not be the best choice computationally. Through the LMC approach in this case, the distribution in (10) is similar to the M CAR(α 1 , . . . , α p , Λ) structure (6), developed in Carlin and Banerjee (2003) and Gelfand and Vounatsou (2003) . All of these have the same number of parameters, and there is no unique joint distribution for φ with the M CAR(
since there is not a unique R j matrix such that R j R j = R j P P R j = D − α j W (P being an arbitrary orthogonal matrix). Carlin and Banerjee (2003) take R j as the Cholesky decomposition of D − α j W , while Gelfand and Vounatsou (2003) instead recommend a spectral decomposition.
Again, a valid joint distribution in (10) requires p valid distributions for u j , i.e.
Through the LMC approach, we can also fit the data with the M CAR(α 1 , . . . , α p , Σ) prior distribution (10) on φ in WinBUGS as in the previous subsection by writing φ = (A ⊗ I n×n )u and assigning proper CAR priors (via the car.proper distribution) with a distinct smoothing parameter α j for each u j , j = 1, . . . , p. As mentioned in the preceding section, we assign a prior to AA = Σ (e.g., an inverse Wishart), and determine A from the one-to-one relationship between the elements of Σ and A; Section 4 below provides details.
Case 3: Dependent and not identical latent processes
Finally, in this case we will assume that the random spatial processes u j = (u 1j , . . . , u nj ) , j = 1, . . . , p are neither independent nor identically distributed. We now assume that u ij and u i, l =j are independent given u k =i, j and u k =i, l =j , where l, j = 1, . . . , p and i, k = 1, . . . , n implying that latent effects for different diseases in the same region are conditionally independent given those for diseases in the neighboring regions. Based upon the Markov property and similar to the conditional distribution given by (3) in the univariate case, we specify the ij th conditional distribution as Gaussian with mean 
where I is a p×p identity matrix and B is a p×p symmetric matrix with the elements b jl , j, l = 1, . . . , p.
As long as the dispersion matrix in (11) is positive-definite, which boils down to (
being positive definite, (11) is itself a valid model. To assess non-singularity, note 
. . , p, ensures the positive definiteness of the matrix I p×p ⊗D −B ⊗W and, hence, the validity of the distribution of u given in (11). In fact, ξ max = 1 and ξ min < 0 (see, e.g., Banerjee et al., 2004) , which makes this formulation easier to work with in practice (e.g. in choosing priors; see Section 4) than the alternative parametrization
The model in (11) introduces smoothing parameters in the cross-covariance structure through the matrix B, but unlike the M CAR models in Sections 3.1 and 3.2 does not have the Σ matrix to capture non-spatial variances. To remedy this, we model φ = (A ⊗ I n×n )u so that the joint distribution for the random effects φ is
Since φ = (A ⊗ I n×n )u, it is immediate that the validity of (11) To see the generality of (12) To understand the features of the M CAR(B, Σ) distribution (12), we illustrate in the bivariate
A, where
. Note that the γ's are not identifiable from the matrix Λ and our reparametrization in terms of B must be used to conduct posterior inference on B and Λ (see Section 4), from which the cross-covariances may be recovered. The above expression does allow the M CAR(B, Σ) distribution (12) to be rewritten as
which is precisely the general dispersion structure we set out to achieve.
To see how the parameters in (13) affect smoothing, we obtain the conditional means
(The conditional moments for special cases such as the separable model in (5) arise by simply setting γ 1 = γ 2 = γ 12 = α.) We note that 
,
. . , φ nl ) , for l = 1, 2 and i, k = 1, . . . , n.
, in both cases for i, k = 1, . . . , n. Thus Case 3 is the most flexible and general with respect to modeling the conditional correlation structure.
Bayesian computation
Our proposed M CAR(B, Σ) model is straightforwardly implemented in a Bayesian framework using MCMC methods. As in Section 3.3, we write φ = (A ⊗ I n×n )u, where u = (u 1 , u 2 ) and
The second term on the right hand side of (14) is
As mentioned in Section 3.3, propriety of this distribution requires the eigenvalues ζ j of B to satisfy , . . . , p) . When p is large, it is hard to determine the intervals over the elements of B that result in 1 ξ min < ζ j < 1, and thus designing priors for B that guarantee this condition is awkward. In principle, one might impose the constraint numerically by assigning a flat prior or a normal prior with a large variance for the elements of B, and then simply check whether the eigenvalues of the corresponding B matrix are in that range during a random-walk MetropolisHastings (MH) update. If the resulting eigenvalues are out of range, the values are thrown out since they correspond to prior probability 0; otherwise we perform the standard MH comparison step. In our experience, however, this does not work well, especially when p is large.
Instead, here we outline a different strategy to update the matrix B. Our approach is to represent B using the spectral decomposition, which we write as B = P ∆P , where P is the corresponding orthogonal matrix of eigenvectors and ∆ is a diagonal matrix of ordered eigenvalues, ζ 1 , . . . , ζ p . We pa- 
In practice, the ζ j must be bounded away from 1 (say, by insisting 1 ξ min < ζ j < 0.999, j = 1, . . . , p) to maintain identifiability and hence computational stability. In fact, with our approach it is also easy to calculate the determinant of the precision matrix, that is,
where ξ i are the eigenvalues of D is the Jacobian. For example, when p = 2, the Jacobian is 4a 2 22 a 11 . Rather than updating Σ as a block using a Wishart proposal, updating the elements a ij of A offers better control.
These are updated via a random-walk Metropolis, using log-normal proposals for the diagonal elements and normal proposals for the off-diagonal elements. With regard to choosing ν and R in the
, if there is no information about the prior mean structure of Σ, a diagonal matrix R can be chosen, with the scale of the diagonal elements being judged using ordinary least squares estimates based on independent models for each response variable. While this leads to a data-dependent prior, typically the Wishart prior lets the data drive the results, leading to robust posterior inference. In this study we adopt ν = 2 (i.e., the smallest value for which this Wishart prior is proper) and R = Diag(0.1, 0.1). Finally, for the remaining terms on the right hand side of (14), flat priors are chosen for β 1 and β 2 , while σ 2 is assigned a vague inverse gamma prior,
i.e. a IG(1, 0.01) parameterized so that E(σ 2 ) = b/(a − 1). In this study, β and σ 2 have closed-form full conditionals, and so can be directly updated using Gibbs sampling.
Simulation study
To evaluate our new approach for modeling multivariate areal data, we begin with some simulation studies. The studies use the spatial layout of the 87 counties in the state of Minnesota, a fairly typical areal arrangement and the one used by our Section 6 data set. We generated count data from a Poisson distribution, as is typical in disease mapping settings
where Y ij is the observed number of cases of cancer type j (one of two types) in region i and log µ ij = β j + φ ij with the β j 's being fixed constants set to β 1 = −0.05 and β 2 = −0.01. These estimates correspond to fitting (15) to esophagus (relatively low incidence) and lung (high incidence) cancer incidence data from Minnesota (see Section 5) using the actual standardized mortalities E ij 's in the simulations.
To assess the relative performance of our proposed model, we designed five simulation studies.
In Study counties i and j, and is calculated using the rdist.earth() function in R using the fields package.
In this model we take the same values of a 11 , a 12 , a 21 , and a 22 as in Study 2.
Simulation results: MSE
To evaluate the performance of our proposed model, we simulated N = 1, 000 data sets, and fit several multivariate models to each. In each study of Table 1 For each data set and model in each study, we first ran a few initially overdispersed paral-lel MCMC chains, and monitored them using measurements of sample autocorrelations within the chains, cross-correlations between parameters, and plots of sample traces. From these, we decided to use 20,000 iterations for the pre-convergence "burn-in" period, and then a further 20,000 iterations as our "production" run for posterior summarization. Unfortunately, the complexity of model (12) precluded us from using the WinBUGS package, so we instead relied on our own programs written in C and executed in R (http://www.r-project.org) using the .C function. Random number generation and posterior summarization were also implemented in R.
To evaluate the relative performance of the models, we compare their average mean squared error (AM SE). Since the true φ ij values are known in the simulation, the AM SE for each disease can be estimated as
with associated Monte Carlo standard error estimate
where φ (r) ij is posterior mean estimate for disease j at county i based on the r-th data set. In our case we have N = 1, 000, n = 87, and j = 1, 2. The GMCAR model also presents some interesting features. Recall that its parametrization is quite rich and it does allow spatially adaptive smoothing of the variances and cross-covariances.
However, its primary drawback lies in its sensitivity to the conditioning order, and this is apparent in In summary, while the M CAR(B, Σ) model consistently produces the lowest AMSE scores in Table 1 , the absolute differences in AMSE among most of the models are rather small, on the order of 10 −2 in our scale. The associated Monte Carlo standard errors of these AMSEs are on the order of 10 −5 , making these differences highly reliable computationally. However, in disease mapping exercises we would not expect to see practical differences among the models. Rather, the main message here is that, despite the rich parametrization of the M CAR(B, Σ) model, it does not appear to be suffering from excessive overfitting (i.e., few negative 's with respect to the true model) while at the same time offering very robust estimation compared to its competitors.
Simulation results: DIC
To investigate the predictive performance of our methods, we now turn to the Deviance Information Criterion, or DIC (Spiegelhalter et al., 2002) as our model choice criterion. This criterion is based on the posterior distribution of the deviance statistic,
where f (y|θ) is the likelihood function for the observed data vector y given the parameter vector θ on which we focus, and h(y) is some standardizing function of the data alone (which thus has no impact on model selection and which we set to 0). The DIC is defined analogously to the AIC as the posterior expected deviance plus the "effective" number of parameters, i.e., DIC = D + p D . Spiegelhalter et al. (2002) show that p D is reasonably defined as
i.e., the expected deviance minus the deviance evaluated at the posterior expectations. Since small values of D indicate good fit while small values of p D indicate a parsimonious model, small values of the sum (DIC) indicate preferred models. Note that a model with more parameters can be "more parsimonious" using p D , since this criterion measures effective model size (i.e., the dimension of the space spanned by the parameters after accounting for shrinkage of the random effects toward their grand mean). DIC is scale-free (because D is), and so no particular score has any intrinsic meaning;
only the ordering of DIC scores across models is meaningful. The use of p D and DIC is not without controversy; in particular, Celeux et al. (2006) highlight several missing data settings where negative p D is a real risk. However, we did not experience this problem with any of our multivariate data models, and so adopt this approach here due to its flexibility and ease of use.
To calculate DIC in our MCMC setting, we only need to calculate the average deviance D, and the deviance of posterior mean, D(θ). Here D(θ) is the same for the models we wish to compare since they differ only in their random effect distributions p(φ|B, Σ), which we do not consider to be part of the likelihood. Specifically, setting 2 log h(
, where L is the likelihood for the Poisson model (15). Table 1 ). Not only does it excel in Study 1, but it actually outperforms the true models in terms of actual DIC in Studies 2 and 3.
In fact, in terms ofD it outperforms all of the true models in Studies 2-4 but marginally loses out to the true GMCAR model in terms of overall DIC due to a substantial increase in the effective number of parameters. The full M CAR(B, Σ) model also dominates the other models in Study 5 even though it, like the rest of the models, is not designed to capture the true geostatistical nature of the simulated data. Although the differences in the average DIC scores in Table 2 are not very large relative to the standard deviations, the ranking of the models is consistently preserved. For instance, the percentage of replicate datasets for which the M CAR(B, Σ) had the lowest DIC score was roughly 99% in Study 1, 57% in Study 2, 86% in Study 3, 47% in Study 4 (the true GMCAR model had lower DIC in the remaining 53% of the replications), and a complete 100% in Study 5.
The behavior of the remainder of the models is also quite similar with results seen for the AMSE and probably with similar reasonings as given there. For instance, we again note the typically poorer 
Data example: Minnesota cancer data
We now turn from the Gaussian likelihood with p = 2 to a non-Gaussian likelihood with p = 3 in a disease mapping context, and illustrate our methods with a data set extracted from the public-use Surveillance, Epidemiology, and End Results (SEER) mortality database (http://seer.cancer.gov).
SEER county-level mortality databases (SEER*Stat Database, 2003) provide the numbers of deaths and corresponding numbers of person-years at risk in quinquennial age brackets for each county in a particular state and each cancer site. Our data consist of the numbers of deaths due to cancers of the lung, larynx, and esophagus in the years from 1990 to 2000 at the county level in Minnesota.
The larynx and esophagus are sites of the upper aerodigestive tract, so they are closely related anatomically. Epidemiological evidence shows a strong and consistent relationship between exposure to alcohol and tobacco and the risk of cancer at these two sites (Baron et al., 1993) . Meanwhile, lung cancer is the leading cause of cancer death for both men and women. An estimated 160,440
Americans will die in 2004 from lung cancer, accounting for 28% of all cancer deaths. It has long been established that tobacco, and particularly cigarette smoking, is the major cause of lung cancer.
More than 87% of lung cancers are smoking-related (http://www.lungcancer.org).
These cancers are rare enough relative to the population in each county that the Poisson spatial regression model (4) in Section 2.2 is appropriate. To calculate the expected counts E ij , we have to take each county's age distribution (over the 18 age groups) into account. To do so, we calculate the expected age-adjusted number of deaths due to cancer j in county i as
is the age-specific death rate due to cancer j for age group k over all Minnesota counties, D k ij is the number of deaths in age group k of county i due to cancer j, and N k i is the total population at risk in county i, age group k, which we assume to be the same for each type of cancer.
Model comparison
The county-level maps of the raw age-adjusted standardized mortality ratios (i.e., SMR ij = Figure 1 we do not consider the order-specific GMCAR model (Jin et al., 2005) , since with no natural causal order for these three cancers, it is hard to choose among the six possible conditioning orders.
To see the relative performance of these models, we again use the DIC criterion. As in the previous section, the deviance D(θ) is the same for the models we wish to compare since they differ only in their random effect distributions p(φ|B, Σ). Specifically, we now have Interestingly, none of the convolution models perform better than their purely spatial counterparts as the improvements inD in the former are insignificant compared to the increase in the effective dimensions brought about. This is indicative of the dominance of the spatial effects over the I.I.D.
effects whence the convolution models seem to be rendering overparametrized models. 
Results from the selected model
In this subsection, we begin by summarizing our results from the M CAR(B, Σ), or Model 1 in Table 3 . Figure 2 , and histograms of the posterior samples b ij in Figure 3 . Table 4 and Figure 2 reveal correlations between cancers, in particular a strong correlation between lung and esophagus (ρ 13 ). This might explain why the DIC scores for Models 1-4 in Table 4 are smaller than that under the separate CAR model. The b ij in Table 4 are spatial autocorrelation and cross spatial correlation parameters for the latent spatial processes u j , j = 1, 2, 3. Figure 3 shows most of the b 12 and b 13 posterior samples are positive; the means of these two parameters are 0.323 and 0.389, respectively. Consistent with the DIC results in Table 3 , these suggest it is worth fitting our proposed M CAR(B, Σ) model to these data. Figure 4 , the correlation among the cancers is apparent, with higher fitted ratios extending from the Twin Cities metro area to the north and northeast (an area where previous studies have suggested smoking may be more common). In Figure 1 , the range of the raw SMRs is seen to be from 0 to 3.3, while in Figure 4 , the range of the fitted SMRs is from 0.7 to 1.3, due to spatial shrinkage in the random effects.
7 Summary and future research model over the existing alternatives as measured by AMSE or DIC, as well as its efficient implementation using MCMC algorithms. Our approach is also readily extended to higher dimensional (p > 2)
settings; the computational burden does not increase much with dimension p since it does not involve large matrix calculations.
Though our emphasis has been on mapping multiple diseases, our proposed MCAR model may also be useful for mapping a single disease. For example, consider a spatially varying coefficients model (Assunção, 2003) extending model (1) in Section 2.1 to
where the x i are explanatory, region-level spatial covariates having parameter coefficients β, and z i1
and z i2 are a subset of x i having spatially varying coefficients ς i1 and ς i2 , respectively. We might suspect ς i1 , ς i2 , or φ i corresponding to counties in geographic proximity to each other might also be similar in magnitude. This in turn means it might be worth fitting a multivariate areal model.
We could take our proposed M CAR(B, Σ) model for Υ = (ς 1 , ς 2 , φ ) , where ς 1 = (ς 11 , . . . , ς n1 ) , ς 2 = (ς 12 , . . . , ς n2 ) , and φ = (φ 1 , . . . , φ n ) .
In our current work, we have only considered mapping the geographic pattern of multiple diseases at a single point in time. However, disease data are often reported over a series of time periods.
For example, the SEER database currently provides cancer mortality information for the years from 1969 to 2001. In such cases, we may be interested in temporal effects as well as spatial effects. This motivates an extension of the proposed MCAR model to multivariate spatiotemporal data. KnorrHeld (2000) proposed a general framework for spatiotemporal modeling of a single disease using ICAR models, which could perhaps be extended to our multivariate setting. Alternatively, we may work with a multivariate Gaussian AR(1) time series of spatial processes in the setting of dynamic models (Gelfand et al., 2005) . This would extend model (4) 
where the x ijt are explanatory, region-level spatial covariates for disease j at time period t having parameter coefficients β jt . Let φ j, t+1 = H j φ j, t + jt , where H j is a n × n matrix, φ jt = (φ 1jt , . . . , φ njt ) and jt = ( 1jt , . . . , njt ) , j = 1, . . . , p. Then we can assume that H j = H = θ 0 I or Finally, here we have studied methods for mapping rare disease rates, the rarity required to ensure the validity of the Poisson approximation to a binomial sampling distribution. However, it is easy to adapt the statistical methods we have presented here to analyze non-rare diseases by replacing the Poisson likelihood with a binomial distribution for the data (MacNab, 2003) . Also while in this paper we considered only mapping disease rates, we also can apply our M CAR(B, Σ) model methodologies when modeling random effects in a hazard function (Carlin and Banerjee, 2003 
